Posar Annio, Visconti Paola
Department of Biomedical and Neuromotor Sciences, University of Bologna, Child Neurology and Psychiatry Unit, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy.
Child Neurology and Psychiatry Unit, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy.
J Pediatr Neurosci. 2016 Jul-Sep;11(3):225-227. doi: 10.4103/1817-1745.193363.
One of the most commonly used complementary and alternative practices in children with autism spectrum disorder (ASD) is the supplementation of omega-3. We describe the case of a child with ASD who seemed to respond to omega-3 supplementation in a relevant and lasting manner. So far, based on the results of randomized clinical trials, evidence-based medicine negates the effectiveness of omega-3 in ASD children. Nevertheless, considering anecdotal experiences, including that of our patient, and nonrandomized trials, the presence of a subgroup of ASD patients who are really responders to omega-3 cannot be excluded. These responders might not appear when evaluating the omega-3 effects in a sample taken as a whole. Studies that check for the possible presence of this subgroup of ASD individuals responders to omega-3 are necessary.
在患有自闭症谱系障碍(ASD)的儿童中,最常用的补充和替代疗法之一是补充ω-3。我们描述了一名患有ASD的儿童的案例,该儿童似乎对ω-3补充剂有显著且持久的反应。到目前为止,基于随机临床试验的结果,循证医学否定了ω-3对ASD儿童的有效性。然而,考虑到包括我们患者在内的轶事经验以及非随机试验,不能排除存在一部分真正对ω-3有反应的ASD患者亚组。在评估整个样本中ω-3的效果时,这些有反应者可能不会出现。有必要开展研究,以检查是否可能存在这一ASD个体对ω-3有反应的亚组。